Comparison of diagnostic accuracy of APRI and Transient Elastography for prediction of esophageal variceal bleed in liver cirrhosis
DOI:
https://doi.org/10.18203/2320-6012.ijrms20231343Keywords:
APRI, CLD, Liver cirrhosis, Transient elastographyAbstract
Background: Liver Cirrhosis is the end-stage for chronic liver disease. Repeated course of endoscopy is recommended, as this intervention is expensive and often poorly accepted by patients, there is a need for non-invasive methods to predicts the progression of portal hypertension as well as the presence and size of esophageal varices. This study was aimed to assess the APRI and Transient Elastography for predicting esophageal variceal bleed in cirrhotic patients. Objectives of the study were to study Diagnostic accuracy of APRI for Prediction of esophageal variceal bleed in liver cirrhosis, diagnostic accuracy of Transient Elastography for Prediction of esophageal variceal bleed in liver cirrhosis, comparison of diagnostic accuracy of APRI and Transient Elastography for Prediction of esophageal variceal bleed in liver cirrhosis.
Methods: It was a Single centre, observational study in 35 patients of chronic liver disease. Patients were included in the study after fulfilling inclusion and exclusion criteria. CBC, LFT, KFT, SE, viral marker, USG whole abdomen, UGIE, Transient Elastography was done. APRI was calculated for every patient.
Results: The APRI and Transient Elastography showed moderate diagnostic accuracy in predicting the presence of esophageal variceal bleed. Transient Elastography performed better for prediction of esophageal variceal bleed.
Conclusions: The APRI and Transient Elastography showed moderate diagnostic accuracy in predicting the presence of esophageal variceal bleed. They help in starting prophylactic therapy earlier to prevent the bleeding and other complications of varices. These non-invasive parameters can also play an effective role in conjunction with endoscopy in predicting the presence of esophageal varices.
Metrics
References
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980- 2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1736-88.
D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44(1):217-31.
Biecker E. Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol 2013;19(31):5035-50
Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353(21):2254-61.
Grace ND & Minor, MA 2012. Portal hypertension and esophageal variceal hemorrhage. In: Greenberger NJ, Blumer RS, Burakoff R (eds), Current diagnosis and treatment,Mc Grew Hill, New York
de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53(4):762-8.
Kumar M, Kumar A, Hissar S, et al. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus. Liver Int 2008;28(5):690-8.
Par G, Trosits A, Pakidi F, Szabo I, Czimer J. Transient elastography as a predictor of esophageal varices in patients with liver cirrhosis. J Orv Hetil 2014;155(7) :270-6.
Walker BR Colledge NR, Ralston SR and Penman ID (eds), 2014. Devidson’s principle and practice of medicine. 22nd ed.Edinburgh, Elsevier.: 942-3.
Sebastiani G, Tempesta D, Fattovich G, Laurent C, Halfon P. Prediction of esophageal varices in hepatic cirrhosis by simple non-invasive markers: Results of a multicenter, large scale study. J Hepatol 2010 ;53:630-8.
Arulprakash Sarangapani, Chitra Shanmugam, Muthukumaran Kalyanasundaram et al : Noninvasive Prediction of Large Esophageal Varices in Chronic liver disease patients: Platelet spleen diameter ratio 909 had a sensitivity and specificity of 88.5%, 83% respectively.
Deng H, Qi X, Peng Y, et al. Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study. Med Sci Monit 2015;21:3961-77.
Hassan E, El-Din S, Sharaf A, et al. Noninvasive Fibrosis Scores as Prognostic Markers for Varices Needing Treatment in Advanced Compensated Liver Cirrhosis. Open Journal of Gastroenterology 2017;7:230-42.
Morishita N, Hiramatsu N, Oze T, et al. Liver stiffness measurement by acoustic radiation force impulse is useful in predicting the presence of esophageal varices or highrisk esophageal varices among patients with HCV-related cirrhosis. J Gastroenterol 2014;49(7):1175-82.
CasteraL,Vergniol j, Fouchar J, Le Bail B, Chanteloup E, Haaser M et al. Prospective comparison of ransientelastography, fibrotest,APRI and liver biopsy for assessment of fibrosis in chronic hepatitis C.Gastroenterology 2013 ;128:343-50.
Tafarel JR, Tolentino LH, Correa LM, Bonita DR, Matin FS. Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers. Eur JGastroenterolHepatol 2011;23:754-8.
Wang JH, Cruah SK, Lu SN, Hung CH, Chen CH. Transient elastography and simple blood markers in the diagnosis of esophageal varices for compensated patients with hepatitis B virus related cirrhosis. JGastroenterolHepatol 2012;27:1213-18.
Kitson MT, Robert SK, Colman JC, Paul E, Button P. Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications, Scandinavian journal of gastroenterology 2015 ;50 :462-469.
Debashis Kumar Sarkar, et al. Prediction of esophageal varices in liver cirrhosis by transient elastography and aspartate aminotransferase - to - platelet ratio index (APRI). Bangladesh Crit Care J March 2018; 6 (1): 16-21.
Downloads
Published
How to Cite
Issue
Section
